Transplant therapy for type 1 diabetes mellitus

Area of Science:

• Endocrinology
• Transplantation immunology
• Metabolic diseases

Background:

• Insulin-dependent diabetes mellitus (IDDM) affects over a million US patients.
• Exogenous insulin therapy has limitations in achieving optimal glycemic control.
• Pancreas transplantation offers a potential cure by restoring euglycemia and regulatory feedback.

Purpose of the Study:

• To review the current status and recent advances in pancreas and islet cell transplantation for IDDM.
• To highlight improvements in immunosuppressive regimens and surgical techniques.
• To discuss the renewed interest in islet cell transplantation due to purification and immunosuppression advancements.

Main Methods:

• Review of current literature on pancreas and islet cell transplantation.
• Analysis of advancements in immunosuppressive therapies.
• Evaluation of surgical technique improvements and their impact on outcomes.

Main Results:

• Pancreas transplantation is the only treatment restoring normal glucose levels and feedback control.
• Improved immunosuppression and surgical techniques have enhanced patient and graft survival rates.
• Advances in islet cell purification and targeted immunosuppression are increasing the viability of islet cell transplantation.

Conclusions:

• Pancreas transplantation remains the gold standard for treating IDDM, offering a cure.
• Ongoing research in immunosuppression and surgical procedures continues to improve outcomes.
• Islet cell transplantation is a promising alternative, with recent advances making it a viable option.